4587 PeptiDream Inc. |
03/28/2025 19:30 | Corporate Governance Report 28/3/2025 |
03/04/2025 08:00 | Notice of Convocation of the 19th Ordinary General Meeting of Shareholders |
02/13/2025 15:30 | Consolidated Financial Results for the Fiscal Year Ended December 31, 2024 [IFRS] |
11/13/2024 15:30 | Consolidated Financial Results for the Nine Months Ended September 30, 2024 [IFRS] |
08/08/2024 15:00 | Consolidated Financial Results for the Six Months Ended June 30, 2024 [IFRS] |
06/14/2024 08:30 | (Amendment to Original Disclosure) PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis |
05/14/2024 15:30 | Consolidated Financial Results for the Three Months Ended March 31, 2024 [IFRS] |
05/14/2024 15:30 | PeptiDream Announces Upward Revision of Financial Forecasts |
04/05/2024 12:25 | Corporate Governance Report 5/4/2024 |